Benzinga's Top Ratings Upgrades, Downgrades For December 23, 2022

Raymond James upgraded The Toro Co TTC's previous Market Perform rating to Outperform. The fourth quarter saw Toro post an EPS value of $1.11 compared to $0.56 in the year-ago quarter. The closing price at the close of the last trading period was $111.15. Loop Capital has downgraded Paramount Global PARA's previous rating from Hold to Sell. The stock currently has a 52 week high of $39.21 and low 52 weeks of $15.29. Paramount Global ended at $16.94 at end of last trading period. Applied Molecular's third quarter EPS was $0.65. This compares to the $0.68 quarter EPS. The stock's 52-week high is $14.94, and its 52-week low is $0.80. Array Technologies seems to have set a price target of $26.00. Array Technologies' stock performance shows a 52 week high of $24.24 (highest 52 weeks) and a 52 week low of $5.45 (lowest 52 weeks). The closing price at the end the last trading period was $20.99. Nutex Health has set a price target of $3.00. Nutex Health reported $0.65 per share in the third quarter as compared with $0.09 in the year-ago quarter. The closing price at the close of the last trading period was $2.12. Daiwa Capital began coverage on First Solar Inc. FSLR with an outperform rating. First Solar reported a $0.46 EPS in the third quarter compared with $0.42 for the same period last year. Stock has a 52 week high of $173.68, and a 52 week low of $59.60. Daiwa Capital began coverage on SolarEdge Technologies Inc. SEDG with a Neutral rating. SolarEdge Technologies seems to have set a price target of $325.00. The stock currently has a 52 week high of $375.90, and a low of $190.15. SolarEdge Technologies ended the last trading session at $311.46. Marsh & McLennan's price target is $157.00 Marsh & McLennan's third quarter EPS was $1.18, compared with the $1.08 quarter EPS. The closing price at $165.70 at the close of the last trading period was also noteworthy. Daiwa Capital began coverage on Enphase Energy Inc ENPH and gave it an Outperform rating. Enphase Energy made $1.25 for the third quarter, as compared to $0.60 for the same period last year. The stock currently has a 52 week high of $339.92, and a low of $113.40. Chardan Capital began coverage on Anixa Biosciences Inc ANIX, with a Buy rating. Anixa Biosciences' price target is $8.00 Anixa Biosciences' stock performance shows that the 52-week high is $6.25, and the 52-week low is $2.30. The closing price at the end the last trading period was $3.81. All analyst ratings initiated.